Annual jab for HIV protection passes trial hurdle

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

from BBC News https://ift.tt/mJtZUeD

Previous article

Disability benefit cuts test loyalty of Labour MPs

Next article

'Some Man Utd players not good enough and overpaid', says club's co-owner